A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression

Rhafaela Lima Causin1, Ana Julia Aguiar de Freitas1, Cassio Murilo Trovo Hidalgo Filho2

  • 1Molecular Oncology Research Center, Barretos Cancer Hospital, Teaching and Research Institute, Barretos-SP 14784-400, Brazil.

Cells
|April 3, 2021
PubMed

Insights

This systematic review identifies 26 differentially expressed microRNAs (DEmiRNAs) crucial for cervical cancer (CC) progression. These microRNAs are linked to key cancer hallmarks and may serve as biomarkers for CC classification and monitoring.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
  • Dysregulation of miRNA expression is implicated in various cancers, including cervical cancer (CC).
  • Understanding miRNA roles in CC progression is vital for developing diagnostic and therapeutic strategies.

Purpose of the Study:

  • To systematically review and analyze studies on miRNA expression in cervical cancer progression.
  • To identify common outcomes and target gene interactions of miRNAs in CC.
  • To explore the potential of miRNAs as biomarkers for CC classification and monitoring.

Main Methods:

  • Systematic literature search of PubMed MEDLINE, EMBASE, and Google Scholar (April 2010-April 2020).
  • Inclusion of 27 published reports involving 1721 CC cases and 1361 noncancerous controls.
  • Analysis based on PICO (participants, interventions, comparisons, outcomes) criteria.

Main Results:

  • Identified 26 differentially expressed microRNAs (DEmiRNAs) across different International Federation of Gynecology and Obstetrics (FIGO) stages of CC.
  • Found associations between specific dysregulated miRNAs and distinct stages of CC development.
  • DEmiRNAs were functionally involved in core cancer hallmarks: evading growth suppressors, replicative immortality, invasion/metastasis, resisting cell death, and sustained proliferation.

Conclusions:

  • Dysregulated miRNAs play a significant role in the development and progression of cervical cancer.
  • Stage-specific miRNAs show potential as biomarkers for CC classification and monitoring.
  • Further research into miRNA regulatory pathways could lead to novel therapeutic targets for CC.